Process View
Any process that modulates the frequency, rate or extent of astrocyte differentiation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of astrocyte differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PLAU | plasminogen activator, urokinase | 0.961 | ||
| RIN3 | Ras and Rab interactor 3 | 0.955 | ||
| JAG1 | jagged 1 | 0.904 | ||
| DNM1 | dynamin 1 | 0.785 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.724 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.629 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.556 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.513 | ||
| ALB | albumin | 0.509 | ||
| EFTUD2 | elongation factor Tu GTP binding domain containing 2 | 0.501 | ||
| NOTCH3 | notch 3 | 0.492 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.427 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.411 | ||
| PLAT | plasminogen activator, tissue | 0.334 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.275 | ||
| SYNJ1 | synaptojanin 1 | 0.254 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.219 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.217 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.184 | ||
| BMP7 | bone morphogenetic protein 7 | 0.176 | ||
| BCAS2 | breast carcinoma amplified sequence 2 | 0.170 | ||
| SF3A1 | splicing factor 3a, subunit 1, 120kDa | 0.168 | ||
| SNX9 | sorting nexin 9 | 0.166 | ||
| HIST1H3B | histone cluster 1, H3b | 0.160 | ||
| MAX | MYC associated factor X | 0.156 | ||
| MAML1 | mastermind-like 1 (Drosophila) | 0.155 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.153 | ||
| U2AF2 | U2 small nuclear RNA auxiliary factor 2 | 0.145 | ||
| U2AF1 | U2 small nuclear RNA auxiliary factor 1 | 0.145 | ||
| SF3A2 | splicing factor 3a, subunit 2, 66kDa | 0.132 | ||
| IL8 | interleukin 8 | 0.132 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.124 | Mouse | |
| PRPF8 | PRP8 pre-mRNA processing factor 8 homolog (S. cerevisiae) | 0.110 | ||
| PRPF6 | PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae) | 0.088 | ||
| IL6R | interleukin 6 receptor | 0.083 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.082 | ||
| JAK1 | Janus kinase 1 | 0.081 | ||
| RBM10 | RNA binding motif protein 10 | 0.079 | ||
| JAK2 | Janus kinase 2 | 0.078 | ||
| SNRNP200 | small nuclear ribonucleoprotein 200kDa (U5) | 0.078 | ||
| FOSL1 | FOS-like antigen 1 | 0.073 | ||
| OSMR | oncostatin M receptor | 0.072 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.071 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.069 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.068 | ||
| ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.068 | ||
| LIFR | leukemia inhibitory factor receptor alpha | 0.066 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.066 | ||
| JAG2 | jagged 2 | 0.062 | ||
| ITSN1 | intersectin 1 (SH3 domain protein) | 0.060 | ||
| BMP2 | bone morphogenetic protein 2 | 0.060 | Mouse | |
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.059 | ||
| FGA | fibrinogen alpha chain | 0.058 | ||
| PRCC | papillary renal cell carcinoma (translocation-associated) | 0.057 | ||
| EGR1 | early growth response 1 | 0.057 | ||
| FGFR2 | fibroblast growth factor receptor 2 | 0.057 | ||
| RNPS1 | RNA binding protein S1, serine-rich domain | 0.057 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.053 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.052 | Mouse | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.052 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.051 | ||
| FSTL1 | follistatin-like 1 | 0.049 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.047 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.045 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.044 | ||
| NOG | noggin | 0.044 | Mouse | |
| DLL1 | delta-like 1 (Drosophila) | 0.042 | ||
| NOTCH2 | notch 2 | 0.041 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.041 | Human | |
| OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.040 | ||
| SPHK1 | sphingosine kinase 1 | 0.039 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.039 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.039 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.036 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.035 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.034 | ||
| SUGP1 | SURP and G patch domain containing 1 | 0.034 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.033 | ||
| IER3 | immediate early response 3 | 0.033 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.032 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.032 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.031 | ||
| SH3GL2 | SH3-domain GRB2-like 2 | 0.031 | ||
| SF3B3 | splicing factor 3b, subunit 3, 130kDa | 0.030 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.030 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.029 | ||
| SMAD7 | SMAD family member 7 | 0.029 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.029 | ||
| BCL2A1 | BCL2-related protein A1 | 0.028 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.028 | ||
| SF3B4 | splicing factor 3b, subunit 4, 49kDa | 0.028 | ||
| HIST1H4F | histone cluster 1, H4f | 0.027 | ||
| KRT8 | keratin 8 | 0.027 | ||
| SART1 | squamous cell carcinoma antigen recognized by T cells | 0.026 | ||
| GPKOW | G patch domain and KOW motifs | 0.026 | ||
| INHBA | inhibin, beta A | 0.026 | ||
| RUNX1 | runt-related transcription factor 1 | 0.025 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.025 | ||
| SF3B2 | splicing factor 3b, subunit 2, 145kDa | 0.025 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.024 | ||
| TNC | tenascin C | 0.024 | ||
| TOE1 | target of EGR1, member 1 (nuclear) | 0.024 | ||
| APCS | amyloid P component, serum | 0.023 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.023 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.023 | ||
| SPEN | spen homolog, transcriptional regulator (Drosophila) | 0.023 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.023 | ||
| MYO1E | myosin IE | 0.022 | ||
| PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 | 0.022 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.022 | Mouse | |
| CTGF | connective tissue growth factor | 0.021 | ||
| FGF18 | fibroblast growth factor 18 | 0.021 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.021 | ||
| EPHA2 | EPH receptor A2 | 0.021 | ||
| EPOR | erythropoietin receptor | 0.021 | ||
| CSNK1E | casein kinase 1, epsilon | 0.021 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.021 | ||
| RBM5 | RNA binding motif protein 5 | 0.021 | ||
| PTAFR | platelet-activating factor receptor | 0.020 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.020 | ||
| SYN2 | synapsin II | 0.020 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.020 | ||
| LTK | leukocyte receptor tyrosine kinase | 0.020 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.020 | ||
| CIR1 | corepressor interacting with RBPJ, 1 | 0.020 | ||
| CNTF | ciliary neurotrophic factor | 0.020 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.020 | ||
| PRKCG | protein kinase C, gamma | 0.019 | ||
| F10 | coagulation factor X | 0.019 | Human | |
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.019 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.018 | ||
| NCAN | neurocan | 0.018 | ||
| MCC | mutated in colorectal cancers | 0.018 | ||
| SF3A3 | splicing factor 3a, subunit 3, 60kDa | 0.018 | ||
| GFI1B | growth factor independent 1B transcription repressor | 0.018 | ||
| PLRG1 | pleiotropic regulator 1 (PRL1 homolog, Arabidopsis) | 0.017 | ||
| SDC4 | syndecan 4 | 0.017 | ||
| LAS1L | LAS1-like (S. cerevisiae) | 0.017 | ||
| PLG | plasminogen | 0.017 | ||
| NHP2L1 | NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae) | 0.017 | ||
| EFNA1 | ephrin-A1 | 0.017 | ||
| CUX1 | cut-like homeobox 1 | 0.017 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.017 | ||
| PTHLH | parathyroid hormone-like hormone | 0.017 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.017 | ||
| THBS1 | thrombospondin 1 | 0.017 | ||
| EMP1 | epithelial membrane protein 1 | 0.017 | ||
| FAM110A | family with sequence similarity 110, member A | 0.017 | ||
| PIM1 | pim-1 oncogene | 0.017 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.017 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.017 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.016 | ||
| SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.016 | ||
| UGCG | UDP-glucose ceramide glucosyltransferase | 0.016 | ||
| CAMKV | CaM kinase-like vesicle-associated | 0.016 | ||
| IL7R | interleukin 7 receptor | 0.016 | ||
| DHX38 | DEAH (Asp-Glu-Ala-His) box polypeptide 38 | 0.016 | ||
| EFNB2 | ephrin-B2 | 0.016 | ||
| FGB | fibrinogen beta chain | 0.016 | ||
| NUDT3 | nudix (nucleoside diphosphate linked moiety X)-type motif 3 | 0.016 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.016 | ||
| GHR | growth hormone receptor | 0.016 | ||
| ATXN1L | ataxin 1-like | 0.016 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.015 | Human | |
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.015 | ||
| FHL1 | four and a half LIM domains 1 | 0.015 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.015 | ||
| TMEM47 | transmembrane protein 47 | 0.015 | ||
| LAMC2 | laminin, gamma 2 | 0.015 | ||
| SEPT4 | septin 4 | 0.015 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.015 | ||
| PER1 | period homolog 1 (Drosophila) | 0.015 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.015 | ||
| LRP2 | low density lipoprotein receptor-related protein 2 | 0.015 | ||
| CLCF1 | cardiotrophin-like cytokine factor 1 | 0.015 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.014 | ||
| DLL3 | delta-like 3 (Drosophila) | 0.014 | Rat | |
| VTN | vitronectin | 0.014 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.014 | ||
| NGFR | nerve growth factor receptor | 0.014 | ||
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.014 | ||
| REPS2 | RALBP1 associated Eps domain containing 2 | 0.014 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.014 | ||
| HUWE1 | HECT, UBA and WWE domain containing 1 | 0.014 | ||
| CADM4 | cell adhesion molecule 4 | 0.014 | ||
| SMAD6 | SMAD family member 6 | 0.014 | ||
| ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) | 0.014 | ||
| GFAP | glial fibrillary acidic protein | 0.014 | ||
| BMP4 | bone morphogenetic protein 4 | 0.014 | ||
| LPHN3 | latrophilin 3 | 0.014 | ||
| IL1A | interleukin 1, alpha | 0.014 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.014 | ||
| EDN1 | endothelin 1 | 0.014 | ||
| SLC6A11 | solute carrier family 6 (neurotransmitter transporter, GABA), member 11 | 0.014 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.014 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.014 | ||
| CHD4 | chromodomain helicase DNA binding protein 4 | 0.014 | ||
| EP300 | E1A binding protein p300 | 0.014 | ||
| RYR3 | ryanodine receptor 3 | 0.014 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.014 | ||
| SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.014 | ||
| PPL | periplakin | 0.014 | ||
| MYOD1 | myogenic differentiation 1 | 0.014 | ||
| CTNNBL1 | catenin, beta like 1 | 0.014 | ||
| GTF3C1 | general transcription factor IIIC, polypeptide 1, alpha 220kDa | 0.014 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.014 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.013 | ||
| LAMB3 | laminin, beta 3 | 0.013 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.013 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.013 | ||
| ZBTB17 | zinc finger and BTB domain containing 17 | 0.013 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.013 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.013 | ||
| SARDH | sarcosine dehydrogenase | 0.013 | ||
| SLC16A3 | solute carrier family 16, member 3 (monocarboxylic acid transporter 4) | 0.013 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.013 | ||
| STC1 | stanniocalcin 1 | 0.013 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.013 | ||
| ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | 0.013 | ||
| FBXW8 | F-box and WD repeat domain containing 8 | 0.013 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.013 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.013 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.013 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.013 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.013 | ||
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.013 | ||
| PTBP1 | polypyrimidine tract binding protein 1 | 0.013 | ||
| EGFL7 | EGF-like-domain, multiple 7 | 0.013 | ||
| C1QL1 | complement component 1, q subcomponent-like 1 | 0.013 | ||
| INSR | insulin receptor | 0.013 | ||
| ACD | adrenocortical dysplasia homolog (mouse) | 0.013 | ||
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.013 | ||
| PTPRD | protein tyrosine phosphatase, receptor type, D | 0.013 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.013 | ||
| GAL3ST1 | galactose-3-O-sulfotransferase 1 | 0.013 | ||
| KNG1 | kininogen 1 | 0.013 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.013 | ||
| EGR3 | early growth response 3 | 0.013 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.013 | ||
| MAN1A1 | mannosidase, alpha, class 1A, member 1 | 0.013 | ||
| FAM110C | family with sequence similarity 110, member C | 0.013 | ||
| SNTG2 | syntrophin, gamma 2 | 0.013 | ||
| CRP | C-reactive protein, pentraxin-related | 0.013 | ||
| NTSR2 | neurotensin receptor 2 | 0.013 | ||
| FGG | fibrinogen gamma chain | 0.012 | ||
| C19orf43 | chromosome 19 open reading frame 43 | 0.012 | ||
| FST | follistatin | 0.012 | ||
| HRH1 | histamine receptor H1 | 0.012 | ||
| SLC6A1 | solute carrier family 6 (neurotransmitter transporter, GABA), member 1 | 0.012 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.012 | ||
| UNC5C | unc-5 homolog C (C. elegans) | 0.012 | ||
| PVR | poliovirus receptor | 0.012 | ||
| SOX10 | SRY (sex determining region Y)-box 10 | 0.012 | ||
| CHST11 | carbohydrate (chondroitin 4) sulfotransferase 11 | 0.012 | ||
| NHLH1 | nescient helix loop helix 1 | 0.012 | ||
| IRS2 | insulin receptor substrate 2 | 0.012 | ||
| TAOK1 | TAO kinase 1 | 0.012 | ||
| IRS1 | insulin receptor substrate 1 | 0.012 | ||
| JMJD6 | jumonji domain containing 6 | 0.012 | ||
| SLC30A3 | solute carrier family 30 (zinc transporter), member 3 | 0.012 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.012 | ||
| RNF130 | ring finger protein 130 | 0.012 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.012 | ||
| IL13RA1 | interleukin 13 receptor, alpha 1 | 0.012 | ||
| SERPINB8 | serpin peptidase inhibitor, clade B (ovalbumin), member 8 | 0.012 | ||
| TBCD | tubulin folding cofactor D | 0.012 | ||
| RPL11 | ribosomal protein L11 | 0.012 | ||
| INHBB | inhibin, beta B | 0.012 | ||
| NDP | Norrie disease (pseudoglioma) | 0.012 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.012 | ||
| CHGB | chromogranin B (secretogranin 1) | 0.012 | ||
| EPHA3 | EPH receptor A3 | 0.012 | ||
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.012 | ||
| FGF9 | fibroblast growth factor 9 (glia-activating factor) | 0.012 | ||
| AMOTL2 | angiomotin like 2 | 0.012 | ||
| HES5 | hairy and enhancer of split 5 (Drosophila) | 0.012 | Mouse | |
| NRCAM | neuronal cell adhesion molecule | 0.012 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.012 | ||
| IGFBP1 | insulin-like growth factor binding protein 1 | 0.012 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.011 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.011 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.011 | ||
| DUSP9 | dual specificity phosphatase 9 | 0.011 | ||
| DMWD | dystrophia myotonica, WD repeat containing | 0.011 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.011 | Human | |
| DYNC1H1 | dynein, cytoplasmic 1, heavy chain 1 | 0.011 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.011 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.011 | ||
| TREM1 | triggering receptor expressed on myeloid cells 1 | 0.011 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.011 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.011 | ||
| CRHBP | corticotropin releasing hormone binding protein | 0.011 | ||
| CD83 | CD83 molecule | 0.011 | ||
| RELN | reelin | 0.011 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.011 | ||
| ELK3 | ELK3, ETS-domain protein (SRF accessory protein 2) | 0.011 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.011 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.011 | ||
| ADD2 | adducin 2 (beta) | 0.011 | ||
| TPST1 | tyrosylprotein sulfotransferase 1 | 0.011 | ||
| PIPOX | pipecolic acid oxidase | 0.011 | ||
| TCF4 | transcription factor 4 | 0.011 | ||
| SFRP5 | secreted frizzled-related protein 5 | 0.011 | ||
| ASCL1 | achaete-scute complex homolog 1 (Drosophila) | 0.011 | ||
| PDLIM4 | PDZ and LIM domain 4 | 0.011 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.011 | ||
| TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.011 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.011 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.011 | ||
| TTYH1 | tweety homolog 1 (Drosophila) | 0.011 | ||
| GLI1 | GLI family zinc finger 1 | 0.011 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.011 | ||
| GAP43 | growth associated protein 43 | 0.011 | ||
| EREG | epiregulin | 0.011 | ||
| BAI1 | brain-specific angiogenesis inhibitor 1 | 0.011 | ||
| APOA2 | apolipoprotein A-II | 0.011 | ||
| NR2F1 | nuclear receptor subfamily 2, group F, member 1 | 0.011 | ||
| MAG | myelin associated glycoprotein | 0.011 | ||
| CELF3 | CUGBP, Elav-like family member 3 | 0.011 | ||
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.011 | ||
| IER2 | immediate early response 2 | 0.011 | ||
| GATA2 | GATA binding protein 2 | 0.011 | ||
| UNC13A | unc-13 homolog A (C. elegans) | 0.011 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.011 | ||
| CCDC17 | coiled-coil domain containing 17 | 0.010 | ||
| PLK3 | polo-like kinase 3 | 0.010 | ||
| CPD | carboxypeptidase D | 0.010 | ||
| EXOC7 | exocyst complex component 7 | 0.010 | ||
| PTX3 | pentraxin 3, long | 0.010 | ||
| SLC1A6 | solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 | 0.010 | ||
| KRT18 | keratin 18 | 0.010 | ||
| DNM3 | dynamin 3 | 0.010 | ||
| FGL1 | fibrinogen-like 1 | 0.010 | ||
| MEF2A | myocyte enhancer factor 2A | 0.010 | ||
| SH3BP4 | SH3-domain binding protein 4 | 0.010 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.010 | ||
| PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 0.010 | ||
| IL11 | interleukin 11 | 0.010 | ||
| SEC14L2 | SEC14-like 2 (S. cerevisiae) | 0.010 | ||
| MSI1 | musashi homolog 1 (Drosophila) | 0.010 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.010 | ||
| CTTN | cortactin | 0.010 | ||
| DPF1 | D4, zinc and double PHD fingers family 1 | 0.010 | ||
| F11 | coagulation factor XI | 0.010 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.010 | ||
| ITIH4 | inter-alpha (globulin) inhibitor H4 (plasma Kallikrein-sensitive glycoprotein) | 0.010 | ||
| GNAO1 | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O | 0.010 | ||
| DVL2 | dishevelled, dsh homolog 2 (Drosophila) | 0.010 | ||
| IL13RA2 | interleukin 13 receptor, alpha 2 | 0.010 | ||
| CXCR2 | chemokine (C-X-C motif) receptor 2 | 0.010 | ||
| NKX2-2 | NK2 homeobox 2 | 0.010 | ||
| SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.010 | ||
| ARL4C | ADP-ribosylation factor-like 4C | 0.010 | ||
| EMX2 | empty spiracles homeobox 2 | 0.010 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.010 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.010 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.010 | ||
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.010 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.010 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.010 | ||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.010 | ||
| G0S2 | G0/G1switch 2 | 0.010 | ||
| ACTN1 | actinin, alpha 1 | 0.010 | ||
| ASTN1 | astrotactin 1 | 0.010 | ||
| RASL10A | RAS-like, family 10, member A | 0.010 | ||
| FBP1 | fructose-1,6-bisphosphatase 1 | 0.010 | ||
| SEZ6L | seizure related 6 homolog (mouse)-like | 0.010 | ||
| F5 | coagulation factor V (proaccelerin, labile factor) | 0.010 | ||
| GCN1L1 | GCN1 general control of amino-acid synthesis 1-like 1 (yeast) | 0.010 | ||
| HOXD9 | homeobox D9 | 0.010 |